• Source: CGP-37849

CGP-37849 is a competitive antagonist at the NMDA receptor. It is a potent, orally active anticonvulsant in animal models, and was researched for the treatment of epilepsy. It also has neuroprotective activity and shows antidepressant and anxiolytic effects.




References

Kata Kunci Pencarian:

• CGP-37849
• NMDA receptor antagonist
• CGP-39551
• Carisoprodol
• Inhalational anesthetic
• Saffron
• Dextromethorphan/bupropion
• Diazoxide
• Zinc
• Ketamine